Aligos Therapeutics: WestPark Capital initiates Buy rating with $48 price target

jueves, 26 de marzo de 2026, 10:19 am ET1 min de lectura
ALGS--

Aligos Therapeutics: WestPark Capital initiates Buy rating with $48 price target

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios